Scientific Articles

Search verified research on molecular hydrogen.

Match

Showing 1–5 of 5 articles

Animal StudyIn VitroHighlighted

The Rieske iron-sulfur protein is a primary target of molecular hydrogen

MHID-8939519PMID: 413302172025Redox Biology

Shuto Negishi, Mikako Ito, Tomoya Hasegawa, Hikaru Otake, Bisei Ohkawara, Akio Masuda, et al.

The mechanisms underlying the biomedical effects of molecular hydrogen (H2) remain poorly understood and are often attributed to its selective reduction of hydroxyl radicals, based on the long-held notion that H2 is biologically inert. We demonstrate that H2 is biologically active, specifically targeting the Rieske iron-sulfur protein (RISP). We first observed that H2 induces the mitochondrial unf

In SilicoHighlighted

Investigation of hydrogenase enzymes and the presence of orthologs in the human proteome

MHID-17877222024Microbes and Immunity

Grace Russell

Hydrogenase enzymes catalyze the reversible oxidation/reduction of hydrogen (H2) and play a crucial role in microbial energy metabolism, with significant implications for human immunity. H2, produced by gut microbes during fermentation or administered exogenously, is vital in modulating oxidative stress and inflammation. In the gastrointestinal tract, microbial H2 production can reach up to 13 L/d

Literature Review

Neuroprotective Effects of Molecular Hydrogen: A Critical Review

MHID-9272690PMID: 330783742021Neuroscience Bulletin

Wei Chen, Han-Ting Zhang, Shu-Cun Qin

Molecular hydrogen (H2) is a physiologically inert gas. However, during the last 10 years, increasing evidence has revealed its biological functions under pathological conditions. More specifically, H2 has protec- tive effects against a variety of diseases, particularly nervous system disorders, which include ischemia/reperfu- sion injury, traumatic injury, subarachnoid hemorrhage, neuropathic pain

Observational StudyHighlighted

Hydrogen gas activates coenzyme Q10 to restore exhausted CD8+ T cells, especially PD-1+Tim3+terminal CD8+ T cells, leading to better nivolumab outcomes in patients with lung cancer

MHID-7483719PMID: 329948212020Oncology Letters

Junji Akagi, Hideo Baba

As previously reported, hydrogen gas improves the prognosis of patients with cancer by restoring exhausted CD8+ T cells into active CD8+ T cells, possibly by activating mitochondria. As mitochondrial activators exhibit synergistic effects with nivolumab, the current study investigated whether hydrogen gas also affects the clinical outcomes of nivolumab. A total of 42 of 56 patients with lung cance

Literature ReviewMechanisms Review

Therapeutic Efficacy of Molecular Hydrogen: A New Mechanistic Insight

MHID-7292103PMID: 310571052019Current Pharmaceutical Design

Toru Ishibashi

Background: Molecular hydrogen (H2) is now recognized as a therapeutic gas for the treatment of numerous diseases including neurodegenerative diseases, metabolic disorders, and inflammatory diseases. Non- polar, neutral H2 is assumed to have health benefits facilitated by its passive diffusion across the human body immediately after administration and is considered a safe therapeutic inert gas tha